Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 5,900 shares at $29.64 ($171K) on 2016-06-13, disclosed to the SEC on 2016-06-15.
Scheduled sale ($171k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.89 | 1,900 | $55K | 32.2% |
| 2 | $28.90 | 1,800 | $52K | 30.5% |
| 3 | $28.90 | 1,900 | $55K | 32.2% |
| 4 | $29.60 | 100 | $3K | 1.7% |
| 5 | $29.64 | 200 | $6K | 3.5% |
| Total | $28.93 avg | 5,900 |
| $171K |
| 100% |
| Filing → |
| ATHA | SELL | 2025-07-02 | $7K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $14K | — | Filing → |
| ATHA | SELL | 2024-09-05 | $3K | — | Filing → |